SCHEMBL4902441

SCHEMBL4902441

CCN(c1ccc(OCC(F)(F)C(F)F)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 4/20 0.42
LMNA P02545 3/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HCRTR2 O43614 1/20 0.41
ESR1 P03372 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
HDAC8 Q9BY41 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
TP53 P04637 2/20 0.39
RECQL P46063 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905605 0.91 LMNA (0.42) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4908889 0.91 LMNA (0.50) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4905352 0.90 NPSR1 (0.41) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4909058 0.83 LMNA (0.50) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4899803 0.83 HCRTR2 (0.53) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4904544 0.83 HCRTR2 (0.53) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4894383 0.82 LMNA (0.44) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4906502 0.82 HDAC8 (0.50) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4899758 0.82 MMP2 (0.49) NPSR1MAPTLMNAALDH1A1SMN1; SMN2
SCHEMBL4903997 0.81 MAPT (0.49) NPSR1MAPTLMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPSR1 735/4885MAPT 1786/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPSR1 735/4885MAPT 1786/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.